119 employees
At Chimerix, we are on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. With a focus in oncology, we are devoted to filling gaps in the treatment paradigm. Show more Show less
$30M sweet spot round size
$30M
from 1 investors over 1 rounds
Chimerix, Inc. raised $30M on January 30, 2025
Investors: Silicon Valley Bank